Clinical trials
Phase 1/2 Biliary Tract Neoplasms trials in Japan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2024 | 3 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 5 |
| Recruiting | 3 |
| Completed | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 2 |
| Amgen | 1 |
| Daiichi Sankyo | 1 |
| Eli Lilly and Company | 1 |
| Kansai Hepatobiliary Oncology Group | 1 |
| Merck Sharp & Dohme LLC | 1 |
| Servier Bio-Innovation LLC | 1 |
| Tanabe Pharma America, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Biliary Tract Neoplasms | 9 |
| Carcinoma, Non-Small-Cell Lung | 5 |
| Colorectal Neoplasms | 4 |
| Endometrial Neoplasms | 4 |
| Ovarian Neoplasms | 4 |
| Stomach Neoplasms | 4 |
| Squamous Cell Carcinoma of Head and Neck | 3 |
| Uterine Cervical Neoplasms | 3 |
| Breast Neoplasms | 2 |
| Carcinoma, Neuroendocrine | 2 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.